Project Grant STZ20023GR0011

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $1,000,000 Cooperative Agreement under the HIV Prevention Activities Health Department Based program (CFDA 93.940) to the Puerto Rico Department of Health (PRDOH) to implement a community health worker-mediated model to re-engage people with HIV who are not in care and reach those who are not virally suppressed in rural communities and municipalities in Puerto Rico. The project aims to strengthen existing agreements with service...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $702,000 to support a 3-year project aimed at optimizing the implementation of long-acting injectable pre-exposure prophylaxis (LAI-PrEP) for HIV prevention. The key objectives are to: 1) Identify barriers and facilitators to LAI-PrEP implementation, 2) Determine optimal implementation strategies in partnership with...

This Project Grant award of $160,000 from the Department of State Bureau of African Affairs supports efforts by Adpp Angola under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) Programs (CFDA 19.029) to prevent mother-to-child transmission of HIV in Angola. Key deliverables include strengthening HIV care and treatment at health facilities, increasing community engagement, and building clinical laboratory and supply chain infrastructure from August 6, 2021 to September 30, 2021....

This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $186,319 to The Regents of the University of California, San Francisco (UCSF) to adapt and test an intervention to reduce HIV-related stigma among pregnant and postpartum women in sub-Saharan Africa. The key activities include: 1) Describing the stigma experiences and mental health impacts of women living with HIV during...

This Project Grant award from the National Institute of Mental Health (NIMH), under the 93.242 Mental Health Research Grants program, will provide $898,186 to Spotted TECH LLC to develop an innovative "CD4-LINK" home-based, mail-in CD4 count test for people living with HIV (PLWH). The overarching goal is to improve HIV monitoring, healthcare management, and facilitate rapid linkage-to-care in underserved areas by reducing the need for clinic visits. The primary objective is to...

This federal Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to implement an innovative HIV self-testing and long-acting injectable HIV treatment and prevention intervention for commercial minibus drivers in Nigeria. The $809,692 award to The George Washington University, with sub-awards to Wake Forest University Health Sciences, University of Rochester, Emory...

This Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) provides $2,207,322 to develop ultra-long-acting prodrug formulations for antiretroviral therapy (ART) to treat HIV-1 infection in pediatric populations. The primary awardee, the Board of Regents of the University of Nebraska through its University of Nebraska Medical Center (UNMC) division, will leverage expertise in pharmaceutical...

This $582,959 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to integrate a "Universal Test-and-Connect" (UTC) strategy for HIV prevention and treatment services into two high-volume emergency department (ED) settings in Cape Town, South Africa. The 3-year project, running from September 2024 to September 2027, has three key objectives: Integrate HIV assessment into...

This federal Project Grant award of $709,872 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to develop and pilot test a couple-based intervention to address perinatal depression and improve adherence to prevention of mother-to-child transmission (PMTCT) of HIV in Malawi. The key objectives are to: 1) develop a couple-based intervention using problem-solving therapy and content on couple...

The federal Project Grant award R01MH135751, with $998,850.00 in funding, was provided by the National Institutes of Health (NIH) under the Trans-NIH Research Support (CFDA 93.310) program. The grant's purpose is to test the effectiveness of an intervention involving daily reminder messages and small monthly prizes to improve long-term adherence to antiretroviral therapy (ART) among people living with HIV. The intervention aims to help participants establish routines for taking their ART...